Chromosomal rearrangement—A rare cause of complement factor I associated atypical haemolytic uraemic syndrome

Immunobiology

Volumn 221, Issue 10, 2016, Pages 1124-1130

  Gleeson, Patrick J ^a   Wilson, Valerie ^b   Cox, Thomas E ^c   Sharma, Seema D ^c   Smith Jackson, Kate ^c   Strain, Lisa ^b   Lappin, David ^a   McHale, Teresa ^a   Kavanagh, David ^c   Goodship, Timothy H J ^c  

^a UNIVERSITY HOSPITAL GALWAY   (Ireland)

^b NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Atypical haemolytic uraemic syndrome; Chromosomal rearrangement; Complement; Factor I; Genetic variants

Indexed keywords

COMPLEMENT; COMPLEMENT FACTOR I;

ADULT; ALLELE; BLOOD; CASE REPORT; CHROMOSOME BREAKAGE; DNA MUTATIONAL ANALYSIS; GENE TRANSLOCATION; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HEMOLYTIC UREMIC SYNDROME; HUMAN; IMMUNOLOGY; MALE; MUTATION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; ATYPICAL HEMOLYTIC UREMIC SYNDROME; CHROMOSOME BREAKPOINTS; COMPLEMENT FACTOR I; COMPLEMENT SYSTEM PROTEINS; DNA MUTATIONAL ANALYSIS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSLOCATION, GENETIC;

EID: 84971629645     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2016.05.002     Document Type: Article

References (20)

1. Alba-Dominguez, M., Lopez-Lera, A., Garrido, S., Nozal, P., Gonzalez-Granado, I., Melero, J., Soler-Palacin, P., Camara, C., Lopez-Trascasa, M., Complement factor I deficiency: a not so rare immune defect: characterization of new mutations and the first large gene deletion. Orphanet J. Rare Dis., 7, 2012, 42.
2. Bienaime, F., Dragon-Durey, M.A., Regnier, C.H., Nilsson, S.C., Kwan, W.H., Blouin, J., Jablonski, M., Renault, N., Rameix-Welti, M.A., Loirat, C., Sautes-Fridman, C., Villoutreix, B.O., Blom, A.M., Fremeaux-Bacchi, V., Mutations in components of complement influence the outcome of factor I-associated atypical hemolytic uremic syndrome. Kidney Int. 77 (2010), 339–349.
3. Challis, R.C., Araujo, G.S.R., Wong, E.K.S., Anderson, H.E., Awan, A., Dorman, A.M., Waldron, M., Wilson, V., Brocklebank, V., Strain, L., Morgan, B.P., Harris, C.L., Marchbank, K.J., Goodship, T.H.J., Kavanagh, D., A de novo deletion in theregulators of complement activation cluster producing a hybrid complement Factor H/Complement Factor H?Related 3 Gene in atypical hemolytic uremic syndrome. J. Am. Soc. Nephrol., 2015, 10.1681/ASN.2015010100.
4. Francis, N.J., McNicholas, B., Awan, A., Waldron, M., Reddan, D., Sadlier, D., Kavanagh, D., Strain, L., Marchbank, K.J., Harris, C.L., Goodship, T.H., A novel hybrid CFH/CFHR3 gene generated by a microhomology-mediated deletion in familial atypical hemolytic uremic syndrome. Blood 119 (2012), 591–601.
5. Fremeaux-Bacchi, V., Miller, E.C., Liszewski, M.K., Strain, L., Blouin, J., Brown, A.L., Moghal, N., Kaplan, B.S., Weiss, R.A., Lhotta, K., Kapur, G., Mattoo, T., Nivet, H., Wong, W., Gie, S., Hurault de Ligny, B., Fischbach, M., Gupta, R., Hauhart, R., Meunier, V., Loirat, C., Dragon-Durey, M.A., Fridman, W.H., Janssen, B.J., Goodship, T.H.J., Atkinson, J.P., Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome. Blood 112 (2008), 4948–4952.
6. Kavanagh, D., Kemp, E.J., Mayland, E., Winney, R.J., Duffield, J.S., Warwick, G., Richards, A., Ward, R., Goodship, J.A., Goodship, T.H., Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome. J. Am. Soc. Nephrol. 16 (2005), 2150–2155.
7. Kavanagh, D., Kemp, E.J., Richards, A., Burgess, R.M., Mayland, E., Goodship, J.A., Goodship, T.H., Does complement factor B have a role in the pathogenesis of atypical HUS?. Mol. Immunol. 43 (2006), 856–859.
8. Kavanagh, D., Pappworth, I.Y., Anderson, H., Hayes, C.M., Moore, I., Hunze, E.M., Bennaceur, K., Roversi, P., Lea, S., Strain, L., Ward, R., Plant, N., Nailescu, C., Goodship, T.H., Marchbank, K.J., Factor I autoantibodies in patients with atypical hemolytic uremic syndrome: disease-associated or an epiphenomenon?. Clin. J. Am. Soc. Nephrol. 7 (2012), 417–426.
9. Kavanagh, D., Goodship, T.H., Richards, A., Atypical hemolytic uremic syndrome. Semin. Nephrol. 33 (2013), 508–530.
10. Kavanagh, D., Yu, Y., Schramm, E.C., Triebwasser, M., Wagner, E.K., Raychaudhuri, S., Daly, M.J., Atkinson, J.P., Seddon, J.M., Rare genetic variants in the CFI gene are associated with advanced age-related macular degeneration and commonly result in reduced serum factor I levels. Hum. Mol. Genet. 24 (2015), 3861–3870.
11. Lemaire, M., Fremeaux-Bacchi, V., Schaefer, F., Choi, M., Tang, W.H., Le Quintrec, M., Fakhouri, F., Taque, S., Nobili, F., Martinez, F., Ji, W., Overton, J.D., Mane, S.M., Nurnberg, G., Altmuller, J., Thiele, H., Morin, D., Deschenes, G., Baudouin, V., Llanas, B., Collard, L., Majid, M.A., Simkova, E., Nurnberg, P., Rioux-Leclerc, N., Moeckel, G.W., Gubler, M.C., Hwa, J., Loirat, C., Lifton, R.P., Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome. Nat. Genet. 45 (2013), 531–536.
12. Maga, T.K., Nishimura, C.J., Weaver, A.E., Frees, K.L., Smith, R.J., Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome. Hum. Mutat. 31 (2010), E1445–E1460.
13. Moore, I., Strain, L., Pappworth, I., Kavanagh, D., Barlow, P.N., Herbert, A.P., Schmidt, C.Q., Staniforth, S.J., Holmes, L.V., Ward, R., Morgan, L., Goodship, T.H.J., Marchbank, K.J., Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4 and with mutations in CFH, CFI, CD46, and C3 in patients with atypical haemolytic uraemic syndrome. Blood 115 (2010), 379–387.
14. Nilsson, S.C., Kalchishkova, N., Trouw, L.A., Fremeaux-Bacchi, V., Villoutreix, B.O., Blom, A.M., Mutations in complement factor I as found in atypical hemolytic uremic syndrome lead to either altered secretion or altered function of factor I. Eur. J. Immunol. 40 (2010), 172–185.
15. Richards, A., Buddles, M.R., Donne, R.L., Kaplan, B.S., Kirk, E., Venning, M.C., Tielemans, C.L., Goodship, J.A., Goodship, T.H.J., Factor H mutations in hemolytic uremic syndrome cluster in exons 18–20, a domain important for host cell recognition. Am. J. Hum. Genet. 68 (2001), 485–490.
16. Richards, A., Kemp, E.J., Liszewski, M.K., Goodship, J.A., Lampe, A.K., Decorte, R., Muslumanoglu, M.H., Kavukcu, S., Filler, G., Pirson, Y., Wen, L.S., Atkinson, J.P., Goodship, T.H.J., Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 12966–12971.
17. Sansbury, F.H., Cordell, H.J., Bingham, C., Bromilow, G., Nicholls, A., Powell, R., Shields, B., Smyth, L., Warwicker, P., Strain, L., Wilson, V., Goodship, J.A., Goodship, T.H., Turnpenny, P.D., Factors determining penetrance in familial atypical haemolytic uraemic syndrome. J. Med. Genet. 51 (2014), 756–764.
18. Venables, J.P., Strain, L., Routledge, D., Bourn, D., Powell, H.M., Warwicker, P., Diaz-Torres, M.L., Sampson, A., Mead, P., Webb, M., Pirson, Y., Jackson, M.S., Hughes, A., Wood, K.M., Goodship, J.A., Goodship, T.H., Atypical haemolytic uraemic syndrome associated with a hybrid complement gene. PLoS Med., 3, 2006, e431.
19. Westra, D., Volokhina, E., van der Heijden, E., Vos, A., Huigen, M., Jansen, J., van Kaauwen, E., van der Velden, T., van de Kar, N., van den Heuvel, L., Genetic disorders in complement (regulating) genes in patients with atypical haemolytic uraemic syndrome (aHUS). Nephrol. Dial. Transplant. 25 (2010), 2195–2202.
20. Zuber, J., Le Quintrec, M., Sberro-Soussan, R., Loirat, C., Fremeaux-Bacchi, V., Legendre, C., New insights into postrenal transplant hemolytic uremic syndrome. Nat. Rev. Nephrol. 7 (2011), 23–35.